Literature DB >> 18253694

Surgical management of spinal cord haemangioblastoma.

D A Shin1, S H Kim, K N Kim, H C Shin, D H Yoon.   

Abstract

BACKGROUND: The surgical management of spinal cord haemangioblastomas is distinct from that of other benign spinal cord tumours and optimal surgical strategy is still being determined because of the rarity of the condition. The aim of this study is to investigate factors that affect the outcome of surgical management. PATIENTS AND METHODS: We retrospectively analysed 24 operations for symptomatic spinal cord haemangioblastomas in 20 patients. Clinical features and surgical results were investigated by medical record review, telephone interviews, angiographic images, and magnetic resonance images (MRI). The mean follow-up period was 5.6 years (range 6 months to 13.6 years).
RESULTS: Patients with cystic components showed pre-operative motor weakness and sensory change more commonly than those without cystic components. Post-operative function scale had a positive correlation with pre-operative function (R(2) = 0.727; p < 0.001) and no correlation with the extent of the surgery. All subtotally removed tumours recurred, whereas totally removed tumours recurred in only 3 patients.
CONCLUSION: The cystic component of spinal cord haemangioblastomas is responsible for symptom generation and is helpful for dissecting tumours. Post-operative functional status is determined by pre-operative functional status. Total removal is feasible by using the correct surgical technique and is recommended to prevent recurrence.

Entities:  

Mesh:

Year:  2008        PMID: 18253694     DOI: 10.1007/s00701-008-1396-6

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  8 in total

1.  The use of magnetic resonance imaging in predicting the clinical outcome of spinal arteriovenous fistula.

Authors:  Dong Ah Shin; Keun Young Park; Gyu Yeul Ji; Seong Yi; Yoon Ha; Seoung Woo Park; Do Heum Yoon; Keung Nyun Kim
Journal:  Yonsei Med J       Date:  2015-03       Impact factor: 2.759

2.  Differentiation of localization of spinal hemangioblastomas based on imaging and pathological findings.

Authors:  Shiro Imagama; Zenya Ito; Norimitsu Wakao; Yoshihito Sakai; Fumihiko Kato; Yasutsugu Yukawa; Koji Sato; Kei Ando; Kenichi Hirano; Ryoji Tauchi; Akio Muramoto; Yoshio Hashizume; Yukihiro Matsuyama; Naoki Ishiguro
Journal:  Eur Spine J       Date:  2011-04-29       Impact factor: 3.134

3.  Early microsurgical treatment for spinal hemangioblastomas improves outcome in patients with von Hippel-Lindau disease.

Authors:  Ali Harati; Jarno Satopää; Lydia Mahler; Romain Billon-Grand; Ahmed Elsharkawy; Mika Niemelä; Juha Hernesniemi
Journal:  Surg Neurol Int       Date:  2012-01-21

4.  Rapid Worsening of Symptoms and High Cell Proliferative Activity in Intra- and Extramedullary Spinal Hemangioblastoma: A Need for Earlier Surgery.

Authors:  Shiro Imagama; Zenya Ito; Kei Ando; Kazuyoshi Kobayashi; Tetsuro Hida; Kenyu Ito; Yoshimoto Ishikawa; Mikito Tsushima; Akiyuki Matsumoto; Hiroaki Nakashima; Norimitsu Wakao; Yoshihito Sakai; Yukihiro Matsuyama; Naoki Ishiguro
Journal:  Global Spine J       Date:  2017-02-01

5.  Spontaneous Arrest of Sporadic Spinal Hemangioblastoma Growth after Postoperative Nodular Recurrence: Case Report.

Authors:  Adam Y Li; Alexander F Post; Jennifer B Dai; Tanvir F Choudhri
Journal:  Cureus       Date:  2018-09-28

Review 6.  Surgical Treatment of Intramedullary Hemangioblastomas: Current State of Problem (Review).

Authors:  S Yu Timonin; N A Konovalov
Journal:  Sovrem Tekhnologii Med       Date:  2021-10-29

7.  Spinal cord hemangioblastomas in von hippel-lindau disease: management of asymptomatic and symptomatic tumors.

Authors:  Tae Yup Kim; Do Heum Yoon; Hyun Chul Shin; Keung Nyun Kim; Seong Yi; Jae Keun Oh; Yoon Ha
Journal:  Yonsei Med J       Date:  2012-11-01       Impact factor: 2.759

8.  Surgical outcome of spinal cord hemangioblastomas.

Authors:  Chang Hyun Park; Chang-Hyun Lee; Seung Jae Hyun; Tae-Ahn Jahng; Hyun-Jib Kim; Ki-Jeong Kim
Journal:  J Korean Neurosurg Soc       Date:  2012-09-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.